GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Accounts Payable & Accrued Expense

Microba Life Sciences (ASX:MAP) Accounts Payable & Accrued Expense : A$7.21 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Accounts Payable & Accrued Expense?

Microba Life Sciences's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$2.80 Mil) to Jun. 2023 (A$4.99 Mil) and increased from Jun. 2023 (A$4.99 Mil) to Dec. 2023 (A$7.21 Mil).

Microba Life Sciences's annual accounts payable & accrued expense increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$2.88 Mil) and increased from Jun. 2022 (A$2.88 Mil) to Jun. 2023 (A$4.99 Mil).


Microba Life Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Microba Life Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Accounts Payable & Accrued Expense Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Accounts Payable & Accrued Expense
2.88 4.99

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable & Accrued Expense 2.96 2.88 2.80 4.99 7.21

Microba Life Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines